Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies
通过靶向酪蛋白激酶2探索已批准药物治疗三阴性乳腺癌的潜力:来自计算研究的启示
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0289887
Shoaib, Tagyedeen H; Ibraheem, Walaa; Abdelrahman, Mohammed; Osman, Wadah; Sherif, Asmaa E; Ashour, Ahmed; Ibrahim, Sabrin R M; Ghazawi, Kholoud F; Miski, Samar F; Almadani, Sara A; ALsiyud, Duaa Fahad; Mohamed, Gamal A; Alzain, Abdulrahim A